As European markets experience a streak of gains, buoyed by encouraging company results and defense stock performances, investors are increasingly looking for stable income opportunities amid ongoing economic uncertainties. In such an environment, dividend stocks can offer attractive yields and potential stability, making them an appealing option for those seeking to balance growth with income in their portfolios.
Name | Dividend Yield | Dividend Rating |
Bredband2 i Skandinavien (OM:BRE2) | 4.91% | ★★★★★★ |
Julius Bär Gruppe (SWX:BAER) | 4.30% | ★★★★★★ |
Zurich Insurance Group (SWX:ZURN) | 4.23% | ★★★★★★ |
Mapfre (BME:MAP) | 5.95% | ★★★★★★ |
Rubis (ENXTPA:RUI) | 7.75% | ★★★★★★ |
Vaudoise Assurances Holding (SWX:VAHN) | 4.30% | ★★★★★★ |
Cembra Money Bank (SWX:CMBN) | 4.40% | ★★★★★★ |
HEXPOL (OM:HPOL B) | 4.20% | ★★★★★★ |
Banque Cantonale Vaudoise (SWX:BCVN) | 4.55% | ★★★★★★ |
Telekom Austria (WBAG:TKA) | 4.76% | ★★★★★☆ |
Click here to see the full list of 223 stocks from our Top European Dividend Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Atresmedia Corporación de Medios de Comunicación, S.A. is an audiovisual company involved in television, radio, digital and multimedia development, cinema, and events organization both in Spain and internationally with a market cap of €1.12 billion.
Operations: Atresmedia Corporación de Medios de Comunicación, S.A. generates its revenue through its operations in television, radio, digital and multimedia development, cinema, and events organization.
Dividend Yield: 9%
Atresmedia Corporación de Medios de Comunicación offers a high dividend yield, ranking in the top 25% of Spanish market payers. Despite its attractive yield, the company's dividend history is marked by volatility and unreliability, with past drops over 20%. Recent earnings show a decline in net income to €120.28 million for 2024 from €171.16 million in 2023, impacting profit margins. However, dividends remain covered by both earnings and cash flows with payout ratios of 56.2% and 61.2%, respectively.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Clínica Baviera, S.A. is a medical company that operates a network of ophthalmology clinics and has a market cap of €557.93 million.
Operations: Clínica Baviera, S.A. generates its revenue primarily from its ophthalmology segment, which accounted for €252.47 million.
Dividend Yield: 4.5%
Clínica Baviera's dividend yield of 4.5% is below the top quartile of Spanish market payers, and its dividend history has been marked by volatility with past annual drops over 20%. Despite this, dividends are well-covered by earnings and cash flows, with payout ratios at 66.6% and 69%, respectively. The stock trades at a significant discount to its estimated fair value, though the reliability of its dividends remains a concern due to past inconsistencies.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Eiffage SA operates in construction, property development, urban development, civil engineering, metallic construction, roads, energy systems, and concessions across France and internationally with a market cap of €9.23 billion.
Operations: Eiffage SA's revenue is primarily derived from its Concessions (€3.89 billion), Construction (€3.98 billion), Energy Systems (€7.21 billion), and Infrastructures (€8.35 billion) segments.
Dividend Yield: 4.9%
Eiffage's recent announcement of a €4.70 annual dividend per share reflects an increase, yet its dividend history is marked by volatility. Despite this, dividends are well-covered with a payout ratio of 42.5% and cash payout ratio of 16.2%. The stock trades at a substantial discount to its fair value and earnings have shown growth, but the high debt level raises concerns about financial stability and the sustainability of future dividends.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:A3M BME:CBAV and ENXTPA:FGR.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。